- Science
- Clinical Trials
- Guide to Clinical Trials Your participation makes a difference
- Clinical Trials in Children Designed to improve kids' health
- Data and Results Sharing our Results
- Integrity and Transparency Building Trust
- Diversity Equity and Representation
- Plain Language Study Results Trial Result Summaries
- Expanded Access & Compassionate Use Possible Treatment Options
- Find a Trial
- Areas of Focus
- Rare Disease Smaller populations but big impact
- Internal Medicine Extending lifespans worldwide
- Inflammation & Immunology Treatment at the molecular level
- Vaccines Preventing the spread of infections
- Oncology The science of optimism
- Anti Infectives Combatting an evolving risk
- Areas of Innovation
- Gene Therapy Breakthroughs become treatments
- Medicinal Sciences The next generation of science
- Precision Medicine Developing tailored medicines
- Maternal Immunization Protecting newborns at the start
- mRNA Technology Unleashing the next wave of scientific innovations
- Diseases & Conditions
- Coronavirus Resources
- Product Pipeline
- Research Sites
- Clinical Trials
- Products
- How Drugs are Made
- Branded vs. Generic Learn the difference
- Biologics & Biosimilars Cures found in nature
- Commitment to Quality Maintaining the highest standards
- Global Supply Strategic manufacturing locations
- Manufacturing Sites Where medicine is made in the U.S.
- Medicine Safety
- Health Literacy Learning to be well
- Treatment Choices Learning about treatment decisions
- Partnering With Patients Helping others by reporting side effects
- Tips for Patients Preventing medication errors
- Reporting Adverse Events
- Counterfeiting Preventing medication errors
- Safety Data Sheets
- Product List
- Product Contacts
- PfizerPro for Professionals
- Patient Assistance Programs
- Distributors
- How Drugs are Made
- Stories
- Newsroom
- About
- People
- Executives Our senior-most leadership
- Board Members The people steering our company
- Scientists Our experts making discoveries
- Patient Stories Our patients
- Colleague Stories Our colleagues
- Responsibility
- Ethics & Compliance Each of us is responsible
- Diversity, Equity, and Inclusion Everyone has something to offer
- EHS Governance
- Environmental Sustainability Our responsiblity to the environment
- Global Impact Meeting urgent needs worldwide
- Health & Safety
- Human Rights Furthering dignity and worth
- Intellectual Property The benefits of fair competition
- Patient Advocacy & Engagement Putting Patients First
- Programs & Policies
- Grants Support for independent research
- Political Partnership Supporting like-minded organizations
- Working with Healthcare Professionals Collaboration to improve lives
- Prescription Value & Pricing How to lower patient costs
- Privacy Principles Commitment to personal data privacy
- Ready for Cures Improving Access to Medicines
- Transparency in Grants Committed to Disclosure
- Investors
- Investors Overview Information for stockholders
- Why Invest Why to join us in our mission
- Events & Presentations Calendar of upcoming events
- Financial Reports Quarterly reports and more
- Investor News Announcements about our performance
- Stock Information Charts and data
- Shareholder Services Information on stock transactions
- Corporate Governance
- Corporate Governance Overview Gaining insight into our performance
- Board Committees & Charters Defining the corporate structure
- The Pfizer Board Policies Ensuring ethical leadership
- Corporate Governance FAQs Learn more about our approach
- Contact Our Directors Email any of our Directors
- History
- Careers
- Partners
- People
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Purpose & Ideals
Three Principles of Responsibility for Artificial Intelligence (AI) in Healthcare
Most people already use artificial intelligence (AI) in their daily lives, sometimes without even thinking about it as being AI-driven. Global positioning systems (GPS) are AI-based navigation applications, for instance, that help us find the quickest route between Points A and B and suggest alternate routes when an accident has jammed up traffic. Artificial intelligence speeds up online shopping by remembering our shopping preferences and recommending similar and complementary products. Arti...
Purpose & Ideals
Equity in Advanced Prostate Cancer Care Begins with Changing the Conversation
Prostate health is not a popular topic of conversation. Even in healthcare settings, patients and providers might be hesitant to discuss prostate health or cancer screening. But talking openly is not only the key to destigmatizing an important topic, it’s one of the first steps in addressing global health inequities that impact those diagnosed with prostate cancer. “In the past 10 years, we have seen advances in the treatment of advanced prostate cancer (aPC), but some people are still being...
Purpose & Ideals
Patients’ Voices Shape the Drug Development Process Through a Preference Survey
Cory Lewis has sickle cell disease. Some days, the pain from the blood disorder hits him hard. Even on days without pain, he worries about his future and the health conditions that might arise. “It’s definitely 365 for me,” he says. As a program coordinator with Sick Cells, a sickle cell disease advocacy organization in Washington, D.C., Lewis regularly educates people about what it’s like to live with this disease—a rare, inherited condition, predominately (but not exclusively) impacting...
Purpose & Ideals
Pfizer's Commitment to Disability Inclusion and Why It Matters at Work
When Rady Johnson contemplates the importance of diversity and inclusion in the workplace, he thinks of his son, Michael. Michael, who is 31, has worked as an office assistant at a travel agency for about 10 years. In the summer, he also works on a maintenance crew at a beach. “He's just the hardest worker that you'll ever see,” says Rady, who is Pfizer's Chief Compliance, Quality & Risk Officer. Michael also lives with an intellectual disability. Rady and his wife, Diane, adopted Michael...
Purpose & Ideals
Counterfeit Prescription Drugs: How Organizations Are Combating the Sale of Fake Meds
In an expensive healthcare system, everybody wants more affordable medicine, but at what physical or emotional cost? If you get caught in a medical fraudster's trap, that cost may be steep. By taking counterfeit prescription drugs (which look real but aren't), you not only run the risk of not receiving the benefits of the intended medication, but fakes can also harm you. Unsuspecting buyers may experience allergic reactions, overdose, or other adverse effects caused by unapproved ingredients...
Purpose & Ideals
How To Identify Fake Medicines
Every morning, as you greet the day and shake your prescribed medicine into your hand, you're trusting that they’re authentic. Worldwide, though, counterfeit medications are more common than some might think. Studies show approximately 10-40% of medicines sold in low- and middle-income countries are counterfeit. In the United States, less than 1% of medicines sold in retail pharmacies are counterfeit.1 By that comparison, the chances of your medication being fake are small, but there's...
Purpose & Ideals
Fake Drugs 101: Facts on Illegal, Counterfeit Drugs
People all over the world rely on medication for things like managing chronic illness, preventing pregnancy, and treating life-threatening diseases. Yet people unknowingly consume counterfeit drugs every day, even in developed countries with well-regulated healthcare systems. They put their lives at risk for something they should be able to trust. The pharmaceutical industry and global drug regulators are constantly working to keep any below-standard and fraudulent drugs out of circulation...
Purpose & Ideals
The Meaning of Moonshot: Lessons in Leadership to Last a Lifetime
ON TUESDAY, DECEMBER 31, 2019, Chinese authorities alerted the World Health Organization to a mysterious virus causing pneumonia-like illness in a small cluster of patients in the city of Wuhan. Shortly after, the novel virus was identified as SARS-CoV-2. Less than a year later, on Tuesday, December 8, 2020, nearly ninety-one-year-old Margaret Keenan received a Pfizer/BioNTech COVID-19 vaccine shot at England’s Coventry University Hospital and became the first person in the world to be...
Purpose & Ideals
Net Zero by 2040: How Pfizer is Fighting Climate Change with Ambitious Science Based Goals
In 2015, on the eve of the Paris Agreement, Pfizer was one of the first companies in the world to seek and gain approval of its greenhouse gas emission reduction goal from the Science Based Targets Initiative (SBTi). Since then, leading scientific researchers, together with coalitions such as SBTi, have urged the private and public sectors to increase their commitments to address the growing urgency of the climate crisis. The science is irrefutable; action is required to meet the goals of the Pa...
Purpose & Ideals
How The Pfizer Foundation is Partnering to Improve Health Outcomes for Black Youth
A conversation with Dr. Clyde Glenn, President of the Essie B. & William Earl Glenn Foundation for Better Living In Sunflower County, Mississippi, one of the poorest counties in the nation, The Pfizer Foundation partners at The Glenn Family Foundation (GFF) are working to improve health and life outcomes by addressing the social determinants of health impacting this community. As defined by the Centers for Disease Control and Prevention, social determinants of health are conditions in the...
Purpose & Ideals
Pfizer’s Institute of Translational Equitable Medicine Addresses Equity in Health Research
When it comes to healthcare, the terms “equitable” and "access" often go hand-in-hand. In order to prevent, treat, and identify diseases that disproportionately impact underserved and minority populations, Pfizer believes that research must be directed to the root causes of healthcare disparities. The recently-launched Institute of Translational Equitable Medicine (ITEM) is intended to do just that: work toward a more equitable future of health care. For Aida Habtezion, M.D., who is Pfizer’s...
Purpose & Ideals
Pfizer's Commitment to Supplier Diversity
While it’s easy to recognize the economic and social benefits that suppliers and their communities receive by doing business with a global biopharmaceutical company such as Pfizer, the benefits are far more mutual than they may seem. Applying innovative perspectives gained from working with suppliers that bring diversity, Pfizer is better able to improve patient care through these connections to a more inclusive group of communities, thus improving health for all. One way Pfizer has worked to...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.